Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial

Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial

Summary: Background: After considerable debate, there is now unequivocal evidence that use of antenatal corticosteroids improves outcomes in preterm neonates when used in women at risk of early preterm birth in reasonably equipped hospitals in low-resource countries. We aimed to evaluate the cost-e...

Full description

Bibliographic Details
Main Authors: Katherine E Eddy, Joshua P Vogel, Nick Scott, Dagnachew Fetene, Tom Tidhar, Olufemi T Oladapo, Gilda Piaggio, My Huong Nguyen, Fernando Althabe, Rajiv Bahl, Suman P N Rao, Ayesha De Costa, Suchita Gupta, Abdullah H. Baqui, Mohammod Shahidullah, Saleha Begum Chowdhury, Salahuddin Ahmed, Saima Sultana, Iffat Ara Jaben, Shivaprasad S Goudar, Sangappa M Dhaded, Yeshita V Pujar, Sunil S Vernekar, Saraswati Welling, Geetanjali M Katageri, Muttappa R Gudadinni, Saumya Nanda, Zahida Qureshi, Harriet Tunu Baraka, Alfred Osoti, George Gwako, John Kinuthia, Samuel Ojo, Adesina Olubukola Adeponle, Ayede Adejumoke Idowu, Ebunoluwa Aderonke Adejuyigbe, Oluwafemi Kuti, Bankole Peter Kuti, Francis Bola Akinkunmi, Weyinmi Emmanuel Kubeyinje, Hadijat Olaide Raji, Olusanya Abiodun, Anthony Dennis Isah, Shabina Ariff, Sajid Bashir Soofi, Lumaan Sheikh, Almas Aamir, Farrukh Raza
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X22003400

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X22003400

Similar Items